6 results about "Amenorrhea" patented technology

This invention relates to methods for treating endometriosis and providing effective contraception. Specifically, it relates to drospirenone in methods for treating endometriosis, endometriosis-associated pelvic pain (EAPP), and / or dysmenorrhea, the method comprising administering drospirenone in a biphasic regimen. The invention also relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, and to pharmaceutical compositions and devices comprising drospirenone administered in such a biphasic regimen.

This invention discloses a temperature-adjustable menstrual-inducing patch, belonging to the field of medical dressing technology, to solve the problems of existing menstrual-inducing products, such as non-adjustable temperature, low efficiency, poor adhesion, and inconvenience of use. The patch has a layered, integrated structure, consisting of a control layer, a dressing layer, and an isolation layer from the outside in, suitable for use around the navel. The control layer integrates a charging module, a temperature regulation module, a heating module, and a main control chip; the dressing layer uses a breathable mesh to wrap a menstrual-inducing herbal composition, achieving synergistic menstrual-inducing effects through heating and medication. This invention features a compact structure, convenient operation, high safety, and no side effects. It can be used as an auxiliary tool for inducing menstruation in amenorrhea patients, suitable for home and travel use, effectively improving menstrual-inducing efficiency and user comfort.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition that warms the uterus, promotes menstruation, and eliminates masses. The TCM composition comprises the following herbs: safflower, peach kernel, bupleurum, leech, sparganium, turmeric, immature bitter orange, chuanxiong rhizome, cinnamon twig, red peony root, peony bark, cyperus rhizome, lindera root, fennel, sappanwood, aconite root, and cuscuta seed. This invention also proposes a method for preparing an external application of the TCM composition and its application. The TCM composition of this invention is suitable for treating gynecological conditions such as amenorrhea, ovarian cysts, polycystic ovary syndrome, and oligomenorrhea. It features a rigorous formulation, combining tonifying and purging methods to address both the symptoms and root cause. Based on years of clinical experience, it demonstrates significant efficacy, minimal irritation, and no side effects.

The present invention relates to drospirenone for use in a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and / or dysmenorrhea, comprising administering drospirenone in a biphasic regimen. The present invention furthermore relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, as well as to a pharmaceutical composition and a kit comprising drospirenone administered in such a biphasic regimen.

The present invention relates to drospirenone for use in a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and / or dysmenorrhea, comprising administering drospirenone in a biphasic regimen. The present invention furthermore relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, as well as to a pharmaceutical composition and a kit comprising drospirenone administered in such a biphasic regimen.

The present application relates to a kind of gonadotropin releasing hormone antagonists, it has the antagonistic activity to gonadotropin releasing hormone, and can be used to prevent or treat sex hormone-dependent diseases, such as benign prostatic hypertrophy, uterine fibroids, endometriosis, uterine fibroids, precocious puberty, amenorrhea, premenstrual syndrome, dysmenorrhea and the like, or its prodrug, or its pharmaceutically acceptable salt, or its hydrate or solvate, and the pharmaceutical composition containing it.